Clinical Management of Herpes Simplex Virus Keratitis.

Diagnostics (Basel)

Pennsylvania College of Optometry, Salus University, Elkins Park, PA 19027, USA.

Published: September 2022

Herpes simplex virus (HSV) keratitis is one of the leading causes of blindness worldwide. Additionally, up to 90% of the population in some countries is seropositive for HSV. HSV can cause a wide spectrum of ocular disease ranging from blepharitis to retinitis. Although the initial clinical expressions of HSV-1 and HSV-2 are similar, HSV-2 has been reported more frequently in association with recurrent HSV disease. Besides irreversible vision loss from keratitis, HSV also causes encephalitis and genital forms of the disease. Despite these statistics, there remains no vaccine against HSV. Current treatment therapies for related ocular diseases include the use of oral and topical antivirals and topical corticosteroids. While effective in many cases, they fail to address the latency and elimination of the virus, making it ineffective in addressing recurrences, a factor which increases the risk of vision loss. As such, there is a need for continued research of other potential therapeutic targets. This review utilized several published articles regarding the manifestations of HSV keratitis, antiviral immune responses to HSV infection, and clinical management of HSV keratitis. This review will summarize the current knowledge on the host-virus interaction in HSV infections, as well as highlighting the current and potential antiviral therapeutics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600940PMC
http://dx.doi.org/10.3390/diagnostics12102368DOI Listing

Publication Analysis

Top Keywords

hsv keratitis
12
hsv
10
clinical management
8
herpes simplex
8
simplex virus
8
vision loss
8
keratitis
5
management herpes
4
virus keratitis
4
keratitis herpes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!